EN | ES | DE | FR | IT | 日本語 | 한국어 | 中文

biotech

July 23, 2021
amgen

Amgen Denied Petition to Rehear Enablement Requirements for Biotech Patents

Amgen Denied Petition to Rehear Enablement Requirements for Biotech Patents   By: Katie Rubino  On June 21, 2021 the Court of Appeals for the Federal Circuit […]
October 31, 2018

Differences Betweeen Medtech and Blockchain IP Strategies (VIDEO)

According to IP experts, outside of technical limitations of blockchain technology, the greatest challenge to becoming mainstream is a lack of trust (no pun intended) that prevents many companies from adopting blockchain into their structure.